Company intelligence / Profile preview
Longeveron
Miami, Florida, United Stateslongeveron.com ↗
- Ownership
- Public · LGVN
- Employees
- ~45
- Development stage
- Other
01
Overview
Longeveron's laromestrocel (Lomecel-B™) has shown positive safety and efficacy signals across multiple clinical trials. In HLHS, the company reported 100% five-year transplant-free survival in a Phase 1 trial versus a historical mortality rate of ~20%. For Alzheimer's disease, their Phase 2a CLEAR MIND study demonstrated improvements in cognitive function, quality of life, and brain volume. The FDA has agreed to consider BLA submission based on interim results from a single pivotal trial for AD. The company is advancing toward pivotal trials with regulatory clarity for both HLHS and AD programs.
- Therapeutic areas
- OtherCardiovascularNeurology
- Modalities
- Allogeneic mesenchymal stem cells (MSCs)Cellular therapy (medicinal signaling cells)
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
No major pharma partnerships disclosed as of May 2025. Seeking strategic partners to support late-stage development/commercialization efforts. Some private partner clinics participate in registry/treatment access outside the US.
04
Financials
- Market cap
- $5.2M
- Total revenue
- $1.2M
- Enterprise value
- $-4.3M
Beyond the preview
Go deeper on Longeveron.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Longeveron.